Skip to main content
S&P 5007,743.98+0.28%DOW52,475.10+0.19%NASDAQ26,549.85+0.27%BTC$81,082.00+0.53%ETH$2,354.08+0.55%GOLD$4,084.10+0.23%OIL$101.97+2.07%
Smart Investors Daily
SID Premium
SH

NASDAQ · SHC

Sotera Health Company

Healthcare · Medical - Diagnostics & Research

$18.49

Up+$0.16 (+0.87%)

Updated Oct 28, 2026, 8:59 PM

SID Score

4.8/10

Composite research score

Smart Money

58/100

Neutral

Market cap
4.8B
P/E ratio
86.59
Dividend yield
0.00%
52-week range
$13.09 – $19.85
Volume
1.82M
Avg. volume
2.22M

Price performance · SHC

SHC price history

1M range · 21 trading sessions · Daily adjusted prices

Prices through Oct 27, 2026

SHC closed at $18.49 after 21 trading sessions, down 0.59% for the selected period.

Last close
$18.49
Period change
-0.59%
Period low
$17.64
Period high
$18.60
Daily close
View OHLC price history
SHC OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Oct 27, 2026$18.39$18.56$18.265$18.491.82M
Oct 26, 2026$18.10$18.49$18.09$18.392.05M
Oct 23, 2026$17.99$18.135$17.865$18.101.69M
Oct 22, 2026$17.65$18.15$17.51$18.132.8M
Oct 21, 2026$17.93$18.16$17.75$17.772.72M
Oct 20, 2026$17.66$18.16$17.66$17.931.8M
Oct 19, 2026$17.92$18.10$17.60$17.641.61M
Oct 16, 2026$18.13$18.52$17.79$17.891.86M
Oct 15, 2026$17.88$18.195$17.71$18.072.43M
Oct 14, 2026$17.82$18.02$17.625$17.732.28M
Oct 13, 2026$18.19$18.315$17.92$18.211.65M
Oct 12, 2026$18.04$18.155$17.945$18.151.56M
Oct 9, 2026$17.83$18.235$17.65$18.061.6M
Oct 8, 2026$17.80$18.25$17.51$17.832.25M
Oct 7, 2026$18.13$18.6934$17.87$17.901.61M
Oct 6, 2026$18.77$18.98$18.19$18.251.65M
Oct 5, 2026$18.28$18.71$18.16$18.552.51M
Oct 2, 2026$17.99$18.47$17.99$18.222.08M
Oct 1, 2026$18.40$18.485$18.09$18.121.64M
Sep 30, 2026$18.68$18.76$18.39$18.492.03M
Sep 29, 2026$18.43$18.65$18.275$18.601.64M

Latest SHC news

The latest Smart Investors Daily articles mentioning SHC.

Stock researchCompany · Overview

SHC research

Overview

Company profile and research snapshot.

Company profile

Sotera Health Co provides sterilization, analytical lab testing, and advisory services to help ensure that medical, pharmaceutical and food products are safe for healthcare practitioners, patients, and consumers. The company operates in three segments: Sterigenics, Nordion, and Nelson Labs. Sterigenics provides outsourced terminal sterilization and irradiation services for medical device, pharmaceutical, food safety, and applications; Nordion provides Co-60 and gamma irradiators, which are the key components to the gamma sterilization process; and Nelson Labs provides outsourced microbiological and analytical chemistry testing for the medical device and pharmaceutical industries. Its geographical segments are the United States, Canada, Europe and other regions.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
$18.50
Implied upside
—
Analysts
—
SHC recent ratings
DateFirmRatingTarget
Oct 14, 2026JP MorganUnderweight—
Aug 7, 2026CitigroupBuy—
Aug 7, 2026JP MorganNeutral—
Aug 7, 2026Piper SandlerOverweight—
Aug 7, 2026BarclaysOverweight—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Oct 21, 2026

Sotera Health Announces Third-Quarter 2026 Earnings Release Date

CLEVELAND, Oct. 21, 2026 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the healthcare industry, today announced its plans to release its financial results for the third quarter ended September 30, 2026 before the market opens on Tuesday, November 3, 2026. Following the release, management will host a conference call at 9:00 a.m. Eastern Time to discuss the Company’s

Yahoo · Oct 9, 2026

Is Sotera Health (SHC) Still A Bargain After A 35% Gain?

Sotera Health has delivered a 35.0% gain over the past three years, yet its recent softer returns leave a clear question for investors who care about cash flows. Is the current share price of US$17.83 still aligned with what the business can generate in hard cash over time, or has sentiment moved ahead of the underlying economics? A 35.0% rise over three years puts real weight on whether Sotera Health's current valuation is still anchored to the cash the business can produce. The company's...

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By